We combine mouse phenotyping, computational, and spectroscopic data to show how the effects of this non-pathogenic variant and the disease-causing Bcs1l mutation converge to exacerbate CIII deficiency and disease progression. The gene discussed is BCS1L; the disease is hyperinsulinemic hypoglycemia, familial, 4.